Article Correctness Is Author's Responsibility: NCCN and AstraZeneca Support Quality Improvements for Lung Cancer Care

The National Comprehensive Cancer Network (NCCN) Oncology Research Program (ORP) and AstraZeneca are collaborating to seek proposals for improving care processes for patients with unresectable stage III and stage IV non-small cell lung cancer (NSCLC).